U.S. Stock News

Cytokinetics reported progress in turning its lead heart drug Myqorzo from a development program into an early commercial product, supported by prior regulatory approvals in the US, Europe, and China. Early physician adoption and patient response, together with Myqorzo’s differentiated mechanism in obstructive hypertrophic cardiomyopathy, are sharpening expectations around its broader clinical and competitive role. Next, we’ll look at how Myqorzo’s early commercial uptake and multi-region...

Whirlpool stock performance snapshot Whirlpool (WHR) stock has been under pressure recently, with the share price around $39.42 and total returns declining over the past month, past 3 months, year to date, and the past 1 year. See our latest analysis for Whirlpool. For Whirlpool, the recent 1 week share price return of 8.93% comes after a tougher stretch, with the 30 day share price return down 9.21% and the 1 year total shareholder return down 61.20%. This suggests recent momentum is...

Viridian Therapeutics (VRDN) is in focus after the U.S. Food and Drug Administration approved Lumvoa for thyroid eye disease, covering both active and chronic forms. The stock moved 6% higher after hours. See our latest analysis for Viridian Therapeutics. Viridian Therapeutics’ latest FDA approval comes after a mixed stretch for holders, with the share price down 40.11% year to date but a 1 year total shareholder return of 26.99%. This suggests sentiment has shifted recently as new catalysts...

Drone defense sits at the crossroads of national security, energy driven inflation stories, and shifting government budgets, yet not every stock in this area is built to handle long procurement cycles or rising funding costs. With inflation trends diverging across regions and bond yields and currencies moving on central bank signals, many investors are focusing on companies with strong balance sheets and solid cash cushions. This Financially Strong Drone Defense Stocks screener filters for...

In late June 2026, Arcutis Biotherapeutics announced FDA approval to extend ZORYVE cream 0.3% plaque psoriasis treatment to children aged 2–5, alongside launching a virtual health platform that connects eczema, seborrheic dermatitis, and plaque psoriasis patients with independent dermatologists for streamlined access to care. This combination of a broader pediatric indication and a company-backed but physician-directed digital access channel could meaningfully influence how ZORYVE reaches...

Aon (AON) has come under focus after being removed from several Russell growth indices. This shift can influence passive fund flows, investor perception, and how growth-focused portfolios treat the stock. See our latest analysis for Aon. Following the Russell growth index removals, Aon’s recent momentum has been mixed, with a 7 day share price return of 3.41% and a year to date share price return that is down 3.65%, alongside a 5 year total shareholder return of 45.21%. If you are reassessing...

Associated Banc-Corp recently announced that Andy Miner has joined as senior director, AI for Corporate & Commercial Banking, where he will lead AI strategy, use cases, delivery, adoption, and oversight of risk and data for the business. By appointing a dedicated AI leader with experience scaling analytics teams at U.S. Bank and Target, Associated is signaling a deeper push to embed data-driven decision-making into its commercial banking operations. Next, we’ll examine how Miner's...

On 27 June 2026, NPK International Inc. (NYSE:NPKI) was reclassified across the Russell index family, joining several growth-focused benchmarks while exiting a range of value-oriented indexes, including the Russell 2000 Value and Russell 3000 Value benchmarks. This broad shift from value to growth classifications signals that index providers now see NPK International’s profile as more aligned with growth characteristics, which can influence how both passive and active investors categorize...

DigitalOcean Holdings (DOCN) is back in focus after a broad reshuffle in the Russell index family, with the stock exiting the Russell 2000 series and entering several Russell 1000 and Midcap benchmarks. See our latest analysis for DigitalOcean Holdings. At a latest share price of $157.03, DigitalOcean Holdings has seen strong momentum build over the past quarter with a 90 day share price return of 79.09%. The 1 year total shareholder return of 460.42% and 5 year total shareholder return of...

Why Paychex dropping from growth indexes matters after strong results Paychex (PAYX) is in focus after solid full year 2026 earnings and fresh 2027 guidance were followed by its removal from several Russell growth benchmarks. This combination raises practical questions for stockholders. The company reported full year revenue of US$6.5b and net income of US$1.8b, alongside a completed US$686 million buyback program, while also being dropped from indexes such as the Russell 1000 Growth and...

Why Arlo Technologies Stock Is Back in Focus Arlo Technologies (ARLO) is drawing fresh attention after announcing an expanded partnership that brings Aloe Care Health’s new ConnectAI wellness calling solution into Home Helpers Home Care’s in-home care offerings for aging clients. The move deepens Arlo Technologies’ role in AI-powered, connected care by linking smart home capabilities with proactive wellness check-ins, medication reminders, and care insights for people who want to remain...

Why F5 Stock Is Back in Focus After AI Security Moves and Market Tailwinds F5 (FFIV) is drawing fresh attention after launching its new AI Security Platform, acquiring SurePath AI, and expanding its Equinix partnership, alongside a broader tech rebound following US Iran de escalation. See our latest analysis for F5. Those AI security announcements and the Equinix partnership have arrived while momentum in F5 stock has been strong, with a 38.9% 90 day share price return and a 180.9% three...

On 27 June 2026, Babcock & Wilcox Enterprises (NYSE: BW) was added to a broad suite of Russell indices, including the Russell 2000, 2500 and 3000 families, spanning both growth and value benchmarks as well as small-cap completeness measures. This unusually wide inclusion across multiple Russell indices can increase the company’s visibility with institutional investors and index-tracking funds that reference these benchmarks. Next, we’ll examine how Babcock & Wilcox’s broad inclusion across...

What SiTime’s Index Moves Mean for Investors SiTime (SITM) has shifted into a new tier of equity benchmarks, joining the Russell 1000, Russell Midcap, and related growth and dynamic indexes while exiting several Russell 2000 variants. For you as an investor, these index changes matter because funds that track the Russell 1000, Russell Midcap, and associated growth benchmarks often adjust their holdings to match the new compositions. That process can influence trading activity in SiTime stock...

In late June 2026, Olema Pharmaceuticals, Inc. (NasdaqGS:OLMA) was added to multiple Russell Growth Benchmarks, including the Russell 2000, 2500, 3000, 3000E, Small Cap Comp, and Microcap Growth indices. This broad index inclusion brings Olema onto the radar of a wide range of index-tracking funds and quantitative investors, potentially changing how the company is positioned in many portfolios. Next, we will examine how Olema’s broad Russell Growth index inclusion shapes its investment...

Defense and aerospace stocks are back in focus after AeroVironment surprised the market, with its shares jumping 21% on revenue that doubled year over year and a funded backlog reaching $1.2b. That move, combined with a record US$75b drone request within a proposed US$1.5t U.S. defense budget for 2027, has drawn attention to companies linked to drones, autonomous systems, and broader military technology. If you are looking for ideas on which stocks could be potential beneficiaries or ones to...

In late June 2026, DENTSPLY SIRONA Inc. was removed from several major Russell benchmarks, including the Russell 1000 and Russell Midcap indexes, and simultaneously added to the Russell 2000, Russell 2000 Value, and Russell 2000 Dynamic indexes, while also filing a US$161.7 million shelf registration related to 15,000,000 common shares for an ESOP offering. This reshuffling shifts DENTSPLY SIRONA’s index footprint from large- and mid-cap toward smaller-cap benchmarks, potentially altering...

In late June 2026, Preformed Line Products Company was removed from multiple Russell value and small-cap benchmark indices, following an earlier affirmation of its regular US$0.21 per-share quarterly dividend payable on July 20, 2026. This wave of index deletions matters because it can trigger mechanical selling by index-tracking funds, potentially altering the stock’s investor base and liquidity profile. Next, we’ll examine how the extensive Russell index removals shape Preformed Line...

UFP Technologies (UFPT) has been removed from the Russell 2000 Dynamic Index, a shift that can prompt rebalancing by index-tracking funds and influence how some investors view the stock’s role in diversified portfolios. See our latest analysis for UFP Technologies. The index removal comes after a period of strong momentum for UFP Technologies, with a 30-day share price return of 19.78% and a 90-day share price return of 36.17%. The 5-year total shareholder return of 356.66% points to a very...

Earlier in 2026, Evercore ISI initiated coverage of PROCEPT BioRobotics with an “Outperform” rating, as the company reported completing enrollment in its WATER IV RP randomized prostate cancer trial and securing FDA approval for the WATER IV AS study. These prostate cancer milestones suggest Aquablation therapy could move beyond benign prostatic hyperplasia into a broader urologic oncology role, drawing fresh analyst attention to PROCEPT’s growth pathway. We’ll now examine how progress in...

With UK GDP slipping 0.1% in April and inflation risks back in focus, many investors are rethinking how much economic stress their portfolios can handle. Consumer staples stocks, which sell everyday essentials, can sometimes offer a steadier ride when growth cools and headlines turn harsher. This article looks at how the latest UK data, conflict in Iran and Bank of England inflation warnings could affect large, defensive companies in this space. Ahead, you will see 3 stocks from our Consumer...

In late June 2026, Brookdale Senior Living Inc. was removed from several Russell growth benchmarks, including the Russell 3000 Growth and Russell 2000 Growth indexes, following routine index reconstitution. This simultaneous loss of multiple index inclusions may alter the company’s shareholder base and liquidity profile, potentially affecting how investors assess Brookdale’s role in senior living portfolios. We’ll now examine how Brookdale’s removal from key Russell growth indexes could...

In the past week, Concentrix Corporation reported second-quarter 2026 results showing revenue of US$2,462.47 million and net income of US$55.28 million, alongside updated guidance that points to minimal constant-currency revenue growth for the third quarter and full fiscal year. Despite meeting revenue expectations and achieving record iX Suite contract signings with very large year-on-year growth, Concentrix reduced its full-year outlook while affirming its dividend and completing a...

Vornado Realty Trust (VNO) recently triggered investor attention after its 50-day moving average crossed above its 200-day moving average. This golden cross coincided with upward revisions to earnings estimates and renewed interest in the stock. See our latest analysis for Vornado Realty Trust. Recent trading has been strong for Vornado Realty Trust, with a 30-day share price return of 17.07% and a 90-day share price return of 52.02%, suggesting building momentum on top of a 3-year total...